Trial Profile
A phase II study of inhaled liposomal cisplatin in patients with non-small cell lung cancer (NSCLC)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Aug 2015 New trial record